Last reviewed · How we verify

Fluid resuscitation

Southeast University, China · FDA-approved active Small molecule

Fluid resuscitation restores circulating blood volume and tissue perfusion by administering intravenous fluids to patients with hypovolemia or shock.

Fluid resuscitation restores circulating blood volume and tissue perfusion by administering intravenous fluids to patients with hypovolemia or shock. Used for Hypovolemic shock (hemorrhagic or non-hemorrhagic), Septic shock, Severe dehydration.

At a glance

Generic nameFluid resuscitation
SponsorSoutheast University, China
ModalitySmall molecule
Therapeutic areaCritical Care / Emergency Medicine
PhaseFDA-approved

Mechanism of action

Fluid resuscitation is a supportive medical intervention rather than a drug with a specific molecular mechanism. It involves the rapid infusion of crystalloid or colloid solutions to restore intravascular volume, improve cardiac output, and restore adequate tissue perfusion in patients experiencing hemorrhagic, septic, or other forms of shock. The goal is to reverse hypotension and prevent end-organ damage.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: